ArticlePharmaceuticals (Basel, Switzerland)2025

The Effects of Inclisiran on the Subclinical Inflammatory Markers of Atherosclerotic Cardiovascular Disease in Patients at High Cardiovascular Risk.

Mateusz Maligłówka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.